BioXcel Therapeutics Statistics
Total Valuation
BTAI has a market cap or net worth of $25.58 million. The enterprise value is $107.88 million.
| Market Cap | 25.58M |
| Enterprise Value | 107.88M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BTAI has 30.88 million shares outstanding. The number of shares has increased by 417.97% in one year.
| Current Share Class | 30.88M |
| Shares Outstanding | 30.88M |
| Shares Change (YoY) | +417.97% |
| Shares Change (QoQ) | +7.85% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 5.67% |
| Float | 26.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.43 |
| Forward PS | 18.16 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 158.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.62
| Current Ratio | 0.62 |
| Quick Ratio | 0.32 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -86.77% |
| Return on Invested Capital (ROIC) | -602.76% |
| Return on Capital Employed (ROCE) | 240.31% |
| Weighted Average Cost of Capital (WACC) | 12.00% |
| Revenue Per Employee | $23,448 |
| Profits Per Employee | -$2.60M |
| Employee Count | 29 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.42% in the last 52 weeks. The beta is 0.27, so BTAI's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -59.42% |
| 50-Day Moving Average | 1.18 |
| 200-Day Moving Average | 1.65 |
| Relative Strength Index (RSI) | 29.76 |
| Average Volume (20 Days) | 1,160,109 |
Short Selling Information
The latest short interest is 4.32 million, so 13.98% of the outstanding shares have been sold short.
| Short Interest | 4.32M |
| Short Previous Month | 3.53M |
| Short % of Shares Out | 13.98% |
| Short % of Float | 16.37% |
| Short Ratio (days to cover) | 6.18 |
Income Statement
In the last 12 months, BTAI had revenue of $680,000 and -$75.33 million in losses. Loss per share was -$4.46.
| Revenue | 680,000 |
| Gross Profit | 247,000 |
| Operating Income | -50.39M |
| Pretax Income | -75.33M |
| Net Income | -75.33M |
| EBITDA | -50.11M |
| EBIT | -50.39M |
| Loss Per Share | -$4.46 |
Balance Sheet
The company has $17.18 million in cash and $100.29 million in debt, with a net cash position of -$83.11 million or -$2.69 per share.
| Cash & Cash Equivalents | 17.18M |
| Total Debt | 100.29M |
| Net Cash | -83.11M |
| Net Cash Per Share | -$2.69 |
| Equity (Book Value) | -105.54M |
| Book Value Per Share | -3.90 |
| Working Capital | -21.09M |
Cash Flow
| Operating Cash Flow | -57.38M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 282,000 |
| Net Borrowing | -8.11M |
| Free Cash Flow | -57.38M |
| FCF Per Share | -$1.86 |
Margins
| Gross Margin | 36.32% |
| Operating Margin | -7,410.44% |
| Pretax Margin | -11,078.53% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BTAI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -417.97% |
| Shareholder Yield | -417.97% |
| Earnings Yield | -304.13% |
| FCF Yield | -231.66% |
Analyst Forecast
The average price target for BTAI is $14.00, which is 1,590.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 1,590.21% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 361.98% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 10, 2025. It was a reverse split with a ratio of 1:16.
| Last Split Date | Feb 10, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
BTAI has an Altman Z-Score of -35.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.62 |
| Piotroski F-Score | 3 |